Long-term effects of immunosuppressive therapy on lung function in scleroderma patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long-term effects of immunosuppressive therapy on lung function in scleroderma patients

Published:2018-08-24 Issue:11 Volume:37 Page:3043-3050
ISSN:0770-3198
Container-title:Clinical Rheumatology
language:en
Short-container-title:Clin Rheumatol

Author:

Pavlov-Dolijanovic Slavica,Vujasinovic Stupar Nada,Zugic Vladimir,Ostojic Predrag,Zekovic Ana,Zivanovic Radnic Tatjana,Jeremic Ivan,Tadic Ivana

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Rheumatology

Link

http://link.springer.com/article/10.1007/s10067-018-4266-0/fulltext.html

Reference36 articles.

1. Steen VD, Conte C, Owens GR, Medsger TA Jr (1994) Severe restrictive lung disease in systemic sclerosis. Arthritis Rheum 37:1283–1289

2. White B (2003) Interstitial lung disease in scleroderma. Rheum Dis Clin N Am 29:371–390

3. Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS et al (2006) A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma. Arthritis Rheum 54:3962–3970

4. Tashkin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst DE, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel DE, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Scleroderma Lung Study Research Group (2006) Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med 354:2655–2666

5. Cappelli S, Guiducci S, Bellando Randone S, Matucci Cerinic M (2013) Immunosuppression for interstitial lung disease in systemic sclerosis. Eur Respir Rev 22:236–243

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnosis and management of connective tissue disease‐associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand*;Respirology;2020-11-24

2. Current therapy of interstitial pneumonia associated with systemic scleroderma;Rheumatology Science and Practice;2020-11-09

3. Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis;Rheumatology;2019-09-19

4. Connective Tissue Disease–Associated Interstitial Lung Disease;Clinics in Chest Medicine;2019-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3